nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CYP2C8—Metabolism—FAR2—bile duct cancer	0.00111	0.00111	CbGpPWpGaD
Naloxone—ALB—Metabolism—FAR2—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—IDH2—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00109	0.00109	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	0.00109	0.00109	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—IL6—bile duct cancer	0.00108	0.00108	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.00108	0.00108	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—IL6—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—IL6—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—IL6—bile duct cancer	0.00106	0.00106	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—NRAS—bile duct cancer	0.00106	0.00106	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—HRAS—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—HRAS—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00104	0.00104	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00104	0.00104	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—HRAS—bile duct cancer	0.00104	0.00104	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—SMAD4—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—HRAS—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—HRAS—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—IL6—bile duct cancer	0.001	0.001	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—IL6—bile duct cancer	0.001	0.001	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	0.001	0.001	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—MMP9—bile duct cancer	0.000993	0.000993	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RNF43—bile duct cancer	0.000992	0.000992	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—IL6—bile duct cancer	0.000992	0.000992	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—TGFB1—bile duct cancer	0.000991	0.000991	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—bile duct cancer	0.000988	0.000988	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—IL6—bile duct cancer	0.000983	0.000983	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—IL6—bile duct cancer	0.000979	0.000979	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—NRAS—bile duct cancer	0.000974	0.000974	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.000968	0.000968	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—HRAS—bile duct cancer	0.000968	0.000968	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—FAR2—bile duct cancer	0.000963	0.000963	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—EGFR—bile duct cancer	0.000963	0.000963	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—bile duct cancer	0.000952	0.000952	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000948	0.000948	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—IDH1—bile duct cancer	0.000945	0.000945	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.000945	0.000945	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP2—bile duct cancer	0.000943	0.000943	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—GNAS—bile duct cancer	0.00093	0.00093	CbGpPWpGaD
Naloxone—TLR4—Immune System—NRAS—bile duct cancer	0.000926	0.000926	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.000926	0.000926	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.000915	0.000915	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—KRAS—bile duct cancer	0.00091	0.00091	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—IL6—bile duct cancer	0.000904	0.000904	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.000895	0.000895	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—EGFR—bile duct cancer	0.000887	0.000887	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000886	0.000886	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—NRAS—bile duct cancer	0.000881	0.000881	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	0.000878	0.000878	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—IL6—bile duct cancer	0.000871	0.000871	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.000857	0.000857	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—GNAS—bile duct cancer	0.000847	0.000847	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—GNAS—bile duct cancer	0.000844	0.000844	CbGpPWpGaD
Naloxone—TLR4—Immune System—EGFR—bile duct cancer	0.000844	0.000844	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RNF43—bile duct cancer	0.000839	0.000839	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—KRAS—bile duct cancer	0.000838	0.000838	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—ERBB2—bile duct cancer	0.000826	0.000826	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000818	0.000818	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—GNAS—bile duct cancer	0.000815	0.000815	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.000813	0.000813	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—EGFR—bile duct cancer	0.000803	0.000803	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000802	0.000802	CbGpPWpGaD
Naloxone—TLR4—Immune System—KRAS—bile duct cancer	0.000797	0.000797	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—HRAS—bile duct cancer	0.000774	0.000774	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—KRAS—bile duct cancer	0.000758	0.000758	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000758	0.000758	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RNF43—bile duct cancer	0.000744	0.000744	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFBR2—bile duct cancer	0.000741	0.000741	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—GNAS—bile duct cancer	0.00074	0.00074	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—IL6—bile duct cancer	0.00074	0.00074	CbGpPWpGaD
Naloxone—CREB1—Immune System—HGF—bile duct cancer	0.000737	0.000737	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—ERBB2—bile duct cancer	0.00073	0.00073	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—HRAS—bile duct cancer	0.000727	0.000727	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—HRAS—bile duct cancer	0.000712	0.000712	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP9—bile duct cancer	0.000709	0.000709	CbGpPWpGaD
Naloxone—CREB1—Disease—SMAD4—bile duct cancer	0.000701	0.000701	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ERBB2—bile duct cancer	0.000701	0.000701	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	0.000692	0.000692	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—GNAS—bile duct cancer	0.000689	0.000689	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—IL6—bile duct cancer	0.000682	0.000682	CbGpPWpGaD
Naloxone—TLR4—Immune System—HRAS—bile duct cancer	0.000678	0.000678	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000674	0.000674	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00065	0.00065	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL6—bile duct cancer	0.000649	0.000649	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—HRAS—bile duct cancer	0.000645	0.000645	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—NRAS—bile duct cancer	0.000629	0.000629	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—GNAS—bile duct cancer	0.000626	0.000626	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC5A5—bile duct cancer	0.000623	0.000623	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—IL6—bile duct cancer	0.000617	0.000617	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000613	0.000613	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.000599	0.000599	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—FAR2—bile duct cancer	0.000594	0.000594	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TGFB1—bile duct cancer	0.000584	0.000584	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000584	0.000584	CbGpPWpGaD
Naloxone—ALB—Hemostasis—GNAS—bile duct cancer	0.000584	0.000584	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—EGFR—bile duct cancer	0.000573	0.000573	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00057	0.00057	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HGF—bile duct cancer	0.000556	0.000556	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—NRAS—bile duct cancer	0.000555	0.000555	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—KRAS—bile duct cancer	0.000541	0.000541	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—IDH2—bile duct cancer	0.00054	0.00054	CbGpPWpGaD
Naloxone—ALB—Metabolism—IDH2—bile duct cancer	0.000537	0.000537	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—NRAS—bile duct cancer	0.000533	0.000533	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS2—bile duct cancer	0.000522	0.000522	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFBR2—bile duct cancer	0.000519	0.000519	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFBR2—bile duct cancer	0.000517	0.000517	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—EGFR—bile duct cancer	0.000506	0.000506	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000505	0.000505	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GNAS—bile duct cancer	0.0005	0.0005	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GNAS—bile duct cancer	0.000499	0.000499	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—SMAD4—bile duct cancer	0.000495	0.000495	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SMAD4—bile duct cancer	0.000491	0.000491	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SMAD4—bile duct cancer	0.00049	0.00049	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—EGFR—bile duct cancer	0.000486	0.000486	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GNAS—bile duct cancer	0.000484	0.000484	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—KRAS—bile duct cancer	0.000478	0.000478	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—IDH2—bile duct cancer	0.00047	0.00047	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—IDH1—bile duct cancer	0.000464	0.000464	CbGpPWpGaD
Naloxone—ALB—Metabolism—IDH1—bile duct cancer	0.000462	0.000462	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—HRAS—bile duct cancer	0.00046	0.00046	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—KRAS—bile duct cancer	0.000459	0.000459	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFBR2—bile duct cancer	0.000453	0.000453	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000443	0.000443	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—IL6—bile duct cancer	0.00044	0.00044	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.00044	0.00044	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GNAS—bile duct cancer	0.000437	0.000437	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000433	0.000433	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SMAD4—bile duct cancer	0.000429	0.000429	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS2—bile duct cancer	0.000426	0.000426	CbGpPWpGaD
Naloxone—CREB1—Immune System—ERBB2—bile duct cancer	0.000425	0.000425	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000425	0.000425	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—HRAS—bile duct cancer	0.000406	0.000406	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—IDH1—bile duct cancer	0.000405	0.000405	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000401	0.000401	CbGpPWpGaD
Naloxone—CREB1—Disease—ERBB2—bile duct cancer	0.000392	0.000392	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HRAS—bile duct cancer	0.00039	0.00039	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—IL6—bile duct cancer	0.000389	0.000389	CbGpPWpGaD
Naloxone—CREB1—Disease—PTGS2—bile duct cancer	0.000384	0.000384	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFBR2—bile duct cancer	0.000383	0.000383	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GNAS—bile duct cancer	0.00037	0.00037	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SMAD4—bile duct cancer	0.000363	0.000363	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000356	0.000356	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—NRAS—bile duct cancer	0.000354	0.000354	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—NRAS—bile duct cancer	0.000353	0.000353	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFBR2—bile duct cancer	0.00034	0.00034	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GNAS—bile duct cancer	0.000328	0.000328	CbGpPWpGaD
Naloxone—CREB1—Immune System—NRAS—bile duct cancer	0.000323	0.000323	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—EGFR—bile duct cancer	0.000323	0.000323	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SMAD4—bile duct cancer	0.000322	0.000322	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—EGFR—bile duct cancer	0.000321	0.000321	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—NRAS—bile duct cancer	0.000309	0.000309	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC5A5—bile duct cancer	0.000306	0.000306	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—KRAS—bile duct cancer	0.000305	0.000305	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC5A5—bile duct cancer	0.000305	0.000305	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—KRAS—bile duct cancer	0.000304	0.000304	CbGpPWpGaD
Naloxone—CREB1—Disease—NRAS—bile duct cancer	0.000299	0.000299	CbGpPWpGaD
Naloxone—CREB1—Immune System—EGFR—bile duct cancer	0.000295	0.000295	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—IDH2—bile duct cancer	0.00029	0.00029	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000287	0.000287	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000285	0.000285	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—EGFR—bile duct cancer	0.000282	0.000282	CbGpPWpGaD
Naloxone—CREB1—Immune System—KRAS—bile duct cancer	0.000278	0.000278	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFB1—bile duct cancer	0.000277	0.000277	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ERBB2—bile duct cancer	0.000275	0.000275	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ERBB2—bile duct cancer	0.000274	0.000274	CbGpPWpGaD
Naloxone—CREB1—Disease—EGFR—bile duct cancer	0.000272	0.000272	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC5A5—bile duct cancer	0.000267	0.000267	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—KRAS—bile duct cancer	0.000266	0.000266	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—NRAS—bile duct cancer	0.000261	0.000261	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS2—bile duct cancer	0.00026	0.00026	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HRAS—bile duct cancer	0.000259	0.000259	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HRAS—bile duct cancer	0.000258	0.000258	CbGpPWpGaD
Naloxone—CREB1—Disease—KRAS—bile duct cancer	0.000257	0.000257	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000249	0.000249	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6—bile duct cancer	0.000248	0.000248	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6—bile duct cancer	0.000247	0.000247	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NRAS—bile duct cancer	0.000244	0.000244	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ERBB2—bile duct cancer	0.00024	0.00024	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—EGFR—bile duct cancer	0.000238	0.000238	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GNAS—bile duct cancer	0.000238	0.000238	CbGpPWpGaD
Naloxone—ALB—Metabolism—GNAS—bile duct cancer	0.000237	0.000237	CbGpPWpGaD
Naloxone—CREB1—Immune System—HRAS—bile duct cancer	0.000237	0.000237	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—bile duct cancer	0.000236	0.000236	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—bile duct cancer	0.000235	0.000235	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—bile duct cancer	0.000227	0.000227	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6—bile duct cancer	0.000226	0.000226	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HRAS—bile duct cancer	0.000226	0.000226	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—KRAS—bile duct cancer	0.000225	0.000225	CbGpPWpGaD
Naloxone—CREB1—Disease—HRAS—bile duct cancer	0.000218	0.000218	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6—bile duct cancer	0.000217	0.000217	CbGpPWpGaD
Naloxone—ALB—Hemostasis—KRAS—bile duct cancer	0.00021	0.00021	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NRAS—bile duct cancer	0.000209	0.000209	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6—bile duct cancer	0.000209	0.000209	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NRAS—bile duct cancer	0.000208	0.000208	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GNAS—bile duct cancer	0.000207	0.000207	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—bile duct cancer	0.000206	0.000206	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ERBB2—bile duct cancer	0.000203	0.000203	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—bile duct cancer	0.000194	0.000194	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—bile duct cancer	0.000194	0.000194	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HRAS—bile duct cancer	0.000191	0.000191	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EGFR—bile duct cancer	0.000191	0.000191	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EGFR—bile duct cancer	0.00019	0.00019	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—bile duct cancer	0.000187	0.000187	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6—bile duct cancer	0.000183	0.000183	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NRAS—bile duct cancer	0.000183	0.000183	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ERBB2—bile duct cancer	0.00018	0.00018	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—KRAS—bile duct cancer	0.00018	0.00018	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—KRAS—bile duct cancer	0.000179	0.000179	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HRAS—bile duct cancer	0.000178	0.000178	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—bile duct cancer	0.000174	0.000174	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—bile duct cancer	0.00017	0.00017	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EGFR—bile duct cancer	0.000167	0.000167	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.000164	0.000164	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—bile duct cancer	0.00016	0.00016	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—bile duct cancer	0.000159	0.000159	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—KRAS—bile duct cancer	0.000157	0.000157	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NRAS—bile duct cancer	0.000154	0.000154	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—bile duct cancer	0.000154	0.000154	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HRAS—bile duct cancer	0.000153	0.000153	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HRAS—bile duct cancer	0.000152	0.000152	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—bile duct cancer	0.000144	0.000144	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EGFR—bile duct cancer	0.000141	0.000141	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—bile duct cancer	0.00014	0.00014	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NRAS—bile duct cancer	0.000137	0.000137	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HRAS—bile duct cancer	0.000134	0.000134	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—KRAS—bile duct cancer	0.000133	0.000133	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6—bile duct cancer	0.000128	0.000128	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—bile duct cancer	0.000128	0.000128	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GNAS—bile duct cancer	0.000128	0.000128	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—bile duct cancer	0.000127	0.000127	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—bile duct cancer	0.000127	0.000127	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EGFR—bile duct cancer	0.000125	0.000125	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—bile duct cancer	0.000118	0.000118	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KRAS—bile duct cancer	0.000118	0.000118	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HRAS—bile duct cancer	0.000113	0.000113	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—bile duct cancer	0.000111	0.000111	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6—bile duct cancer	0.000108	0.000108	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—bile duct cancer	0.000105	0.000105	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HRAS—bile duct cancer	0.0001	0.0001	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6—bile duct cancer	9.59e-05	9.59e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—bile duct cancer	6.86e-05	6.86e-05	CbGpPWpGaD
